M.M.Warburg & CO
Corporate FinanceEquity Capital Markets
Equity Capital Markets
Our Equity Capital Markets activities benefit from both our equity sales department, with its strong record of placements and first-class equity research, and our Corporate Finance department which has sucessfully excuted numerous capital markets transactions. We provide support by
- taking on leading mandates for IPOs, capital increases and structured placements
- participating in underwriting syndicates for large, international placements
- advising issuers and companies during capital market transactions
- assisting public purchase offers
- preparing fairness opinions
- assisting approval application placements within the framework of listing and non-cash capital increases
- executing share buyback and employee participation programmes
- as well as other technical handlings
Your contact
Dr. Roman Rocke
Head of Corporate Finance
M.M.Warburg & CO
Phone +49 40 3282-2155
Felix Pröfrock
Head of ECM
M.M.Warburg & CO
Phone +49 40 3282-2275
Current references
No matching entries were found
ECM • September 2021 • Healthcare & Life Sciences
BRAIN Biotech / capital increase
More
ECM • August 2021 • Renewables / Cleantech
7C Solarparken / capital increase
More
ECM • June 2021 • Consumer Goods
Cherry AG / IPO
More
ECM • June 2021 • Renewables / Cleantech
clearvise / capital increase
More
ECM • May 2021 • Healthcare & Life Sciences
APONTIS PHARMA / IPO
More
ECM • April 2021 • Industrials
Katek / IPO
More
ECM • April 2021 • Renewables / Cleantech
clearvise / capital increase
More
ECM • February 2021 • TMT
secunet Security Networks AG / secondary placement
More
ECM • January 2021 • TMT
Fabasoft AG / secondary placement
More
ECM • December 2020 • Renewables / Cleantech
7C Solarparken / capital increase
More